Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “GSK”

A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of AcneCompleted
NCT00887484Phase 4Updated Dec 13, 2016
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
Argentina
A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial AcneCompleted
NCT00964223Phase 4Updated Nov 23, 2016
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With AcneCompleted
NCT00776919Phase 3Updated Nov 23, 2016
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States, Belize, Canada
Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque PsoriasisCompleted
NCT01745133Phase 4Updated Nov 17, 2016
Sponsor: Leon Kircik, M.D.
Psoriasis
United States
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 StudiesCompleted
NCT00689481Phase 3Updated Oct 7, 2016
Sponsor: Stiefel, a GSK Company
Psoriasis
United States
Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy AdultsCompleted
NCT02034500Phase 1Updated Jun 21, 2016
Sponsor: GSK Vaccines Institute For Global Health S.r.l.
Shigellosis
United Kingdom
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United StatesCompleted
NCT00724867Phase 3Updated Mar 28, 2016
Sponsor: Human Genome Sciences Inc., a GSK Company
Systemic Lupus Erythematosus
United States
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne MedicationsCompleted
NCT00926367Phase 4Updated May 20, 2015
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type PsoriasisWithdrawn
NCT00832364Phase 4Updated Apr 21, 2015
Sponsor: Stiefel, a GSK Company
Plaque Psoriasis
United States
Bioequivalence of Two Commercial Amoxicillin SuspensionsCompleted
NCT01933698Phase 4Updated Sep 2, 2013
Sponsor: University of Campinas, Brazil
Bioequivalence of Amoxicillin
Brazil
A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) StudiesCompleted
NCT01858792N/AUpdated May 21, 2013
Sponsor: Human Genome Sciences Inc., a GSK Company
Lupus Erythematosus, Discoid
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesSuspended
NCT01604863Phase 1Updated Nov 1, 2012
Sponsor: Human Genome Sciences Inc., a GSK Company
Cancer
United States
Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99No Longer Available
NCT00931086N/AUpdated Oct 31, 2012
Sponsor: Human Genome Sciences Inc., a GSK Company
Rheumatoid Arthritis
United States
A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaCompleted
NCT00712855Phase 1Updated Oct 30, 2012
Sponsor: Human Genome Sciences Inc., a GSK Company
Hepatocellular Carcinoma
United States
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand DermatitisCompleted
NCT00828464Phase 4Updated Oct 3, 2012
Sponsor: Stiefel, a GSK Company
Hand Dermatosis
United States
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type PsoriasisCompleted
NCT00852761Phase 4Updated Apr 23, 2012
Sponsor: Stiefel, a GSK Company
Plaque-Type Psoriasis
United States
Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and InfantsCompleted
NCT00702507Phase 4Updated Mar 27, 2012
Sponsor: Stiefel, a GSK Company
Diaper Rash
United States, Dominican Republic, Ecuador, Panama
Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of AcneCompleted
NCT00807014Phase 4Updated Mar 20, 2012
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
Spain
Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical TretinoinTerminated
NCT00240513Phase 4Updated Feb 24, 2012
Sponsor: Derm Research @ 888 Inc.
Acne Vulgaris
Canada
Study on Anti-inflammatory Effects of Topical R115866 GelCompleted
NCT00719121Phase 1Updated Sep 26, 2011
Sponsor: Stiefel, a GSK Company
Cutaneous Inflammation
Belgium
An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial AcneCompleted
NCT00725439Phase 2Updated Sep 26, 2011
Sponsor: Stiefel, a GSK Company
Acne
Belgium, Netherlands
Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar IchthyosisCompleted
NCT00282724Phase 2, Phase 3Updated Sep 26, 2011
Sponsor: Stiefel, a GSK Company
Ichthyosis, Lamellar
Belgium, Canada, Dominican Republic, France, Germany +4 more
Study to Assess Blood Levels of Itraconazole During a Two-Week PeriodCompleted
NCT00695071Phase 1Updated Sep 26, 2011
Sponsor: Stiefel, a GSK Company
Healthy
United States
An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type PsoriasisCompleted
NCT00725348Phase 2Updated Sep 26, 2011
Sponsor: Stiefel, a GSK Company
Psoriasis
Netherlands
Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?Unknown
NCT01228409Phase 4Updated Jun 22, 2011
Sponsor: Frankel, Amylynne, M.D.
Psoriasis
United States

Previous page Next page